D.E. Shaw & Co’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-62,955
| Closed | -$382K | – | 3102 |
|
|
2024
Q3 | $382K | Sell |
62,955
-526
| -0.8% | -$3.19K | ﹤0.01% | 2592 |
|
|
2024
Q2 | $334K | Sell |
63,481
-1,600
| -2% | -$8.42K | ﹤0.01% | 2639 |
|
|
2024
Q1 | $553K | Sell |
65,081
-134,572
| -67% | -$1.14M | ﹤0.01% | 2371 |
|
|
2023
Q4 | $1.32M | Buy |
199,653
+31,603
| +19% | +$209K | ﹤0.01% | 1933 |
|
|
2023
Q3 | $519K | Hold |
168,050
| – | – | ﹤0.01% | 2307 |
|
|
2023
Q2 | $454K | Sell |
168,050
-4,171
| -2% | -$11.3K | ﹤0.01% | 2369 |
|
|
2023
Q1 | $511K | Sell |
172,221
-78,164
| -31% | -$232K | ﹤0.01% | 2506 |
|
|
2022
Q4 | $631K | Sell |
250,385
-249,448
| -50% | -$629K | ﹤0.01% | 2627 |
|
|
2022
Q3 | $910K | Buy |
499,833
+159,207
| +47% | +$290K | ﹤0.01% | 2593 |
|
|
2022
Q2 | $1.07M | Buy |
340,626
+39,834
| +13% | +$125K | ﹤0.01% | 2653 |
|
|
2022
Q1 | $1.86M | Buy |
300,792
+166,278
| +124% | +$1.03M | ﹤0.01% | 2483 |
|
|
2021
Q4 | $1.91M | Sell |
134,514
-181,217
| -57% | -$2.57M | ﹤0.01% | 2400 |
|
|
2021
Q3 | $2.53M | Buy |
+315,731
| New | +$2.53M | ﹤0.01% | 1951 |
|